Sonoma, MicroSafe announce Australian TGA approval for NanoCyn extended claims

Sonoma Pharmaceuticals and its partner, the MicroSafe Group DMCC, announce that the Australian Therapeutic Goods Administration has approved extended claims for Nanocyn Disinfectant and Sanitizer, which is manufactured by Sonoma for its partner MicroSafe using Sonoma’s patented Microcyn technology. Nanocyn was previously approved by the TGA and entered into The Australian Register of Therapeutic Goods with a 15 second kill time against SARS-CoV-2, and a 30 second kill time against Norovirus, Influenza A, and bacteria, such as Staphylococcus aureus, E. coli, Pseudomonas aeruginosa. The TGA has now also approved Nanocyn for use against Candida auris and Clostritium Difficile in ten minutes.